Beijing Hotgen Biotech Co Ltd (688068) - Total Liabilities

Latest as of September 2025: CN¥278.25 Million CNY ≈ $40.72 Million USD

Based on the latest financial reports, Beijing Hotgen Biotech Co Ltd (688068) has total liabilities worth CN¥278.25 Million CNY (≈ $40.72 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Beijing Hotgen Biotech Co Ltd to track the company's year-over-year net asset growth rate.

Beijing Hotgen Biotech Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Beijing Hotgen Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Beijing Hotgen Biotech Co Ltd (688068) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Beijing Hotgen Biotech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Beijing Hotgen Biotech Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
ROBEX Resources Inc AU:RXR	Australia	AU$382.96 Million
MY EG Services Bhd KLSE:0138	Malaysia	RM1.83 Billion
Nazara Technologies Limited NSE:NAZARA	India	Rs7.88 Billion
China Resources Chemical Innovative Materials Co. Ltd. SHE:301090	China	CN¥2.13 Billion
Hong Leong Industries Bhd KLSE:3301	Malaysia	RM725.26 Million
CT Real Estate Investment Trust TO:CRT-UN	Canada	CA$3.33 Billion
IMDEX Ltd AU:IMD	Australia	AU$200.79 Million
York Space Systems Inc. NYSE:YSS	USA	$326.70 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Beijing Hotgen Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688068 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.09	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.09	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Beijing Hotgen Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Beijing Hotgen Biotech Co Ltd (2016–2024)

The table below shows the annual total liabilities of Beijing Hotgen Biotech Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥251.77 Million ≈ $36.84 Million	+24.29%
2023-12-31	CN¥202.56 Million ≈ $29.64 Million	-62.87%
2022-12-31	CN¥545.59 Million ≈ $79.84 Million	-29.24%
2021-12-31	CN¥771.01 Million ≈ $112.82 Million	+395.12%
2020-12-31	CN¥155.72 Million ≈ $22.79 Million	+103.89%
2019-12-31	CN¥76.37 Million ≈ $11.18 Million	+34.75%
2018-12-31	CN¥56.68 Million ≈ $8.29 Million	+102.42%
2017-12-31	CN¥28.00 Million ≈ $4.10 Million	-3.91%
2016-12-31	CN¥29.14 Million ≈ $4.26 Million	--

About Beijing Hotgen Biotech Co Ltd

SHG:688068 China Biotechnology

Market Cap

$1.41 Billion

CN¥9.66 Billion CNY

Market Cap Rank

#7456 Global

#1635 in China

Share Price

CN¥104.19

Change (1 day)

+0.10%

52-Week Range

CN¥75.10 - CN¥245.83

All Time High

CN¥250.80